Thank you for your response. But several questions remain. 1) How is the "abnormal" epitope recognized as such? This is where the MHC proteins come into play, but unfortunately I am not clear on the details of how that works. 2) What guarantees that an internal cellular abnormality will always be expressed by a cell surface epitope where it can be recognized?